Results 181 to 190 of about 492,595 (235)
Some of the next articles are maybe not open access.

Synthesis and QSAR Studies on Thiazolidinones as Anti-HIV Agents

Combinatorial Chemistry & High Throughput Screening, 2005
Selected 4-thiazolidinone have been synthesized and tested as anti-HIV activity. The results of the in vitro tests showed that one of the compounds, 5, inhibited the enzyme at 0.204 microM concentration with minimal toxicity to MT-4 cell. Furthermore, the QSAR studies indicated the role of PMIZ, Ovality and Total energy content of the compounds in ...
Ravindra K. Rawal   +4 more
openaire   +3 more sources

Researchers Explore New Anti-HIV Agents

JAMA, 2002
SEATTLE—While antiretroviral drugs have done much to extend the lives of people infected with HIV, severe adverse effects and rising levels of drug resistance can limit their usefulness and are driving efforts to develop new antiHIV medications. Building on knowledge of HIV gleaned from laboratory studies of the virus, researchers are developing and ...
openaire   +2 more sources

Functional Roles of Azoles Motif in Anti-HIV Agents

Current Medicinal Chemistry, 2011
Currently, there has been considerable interest in the discovery of original molecules with broad-spectrum anti-HIV activity and favourable pharmacokinetic profiles, to be used as an alternative to the approved anti-HIV/AIDS drugs, should they fail as therapeutics.
Dongyue Li   +4 more
openaire   +3 more sources

Transport, metabolism and elimination mechanisms of anti-HIV agents

Advanced Drug Delivery Reviews, 1999
Currently available anti-HIV drugs can be classified into three categories: nucleoside analogue reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, and protease inhibitors. Knowledge of these anti-HIV drugs in various physiological or pharmacokinetic compartments is essential for design and development of drug delivery ...
William K. Chan, Xiaoling Li
openaire   +3 more sources

Bioactive prenylated coumarins as potential anti-inflammatory and anti-HIV agents from Clausena lenis.

Bioorganic chemistry (Print), 2020
Yan-Ping Liu   +8 more
semanticscholar   +1 more source

Sulfur Metabolism in AIDS: Cystamine as an Anti-HIV Agent

AIDS Research and Human Retroviruses, 2009
Numerous reports have documented disturbances of sulfur metabolism in AIDS patients. There is a generalized loss of sulfur from the body, measured as cysteine and glutathione. The enzyme, cystathionase, has been shown to be greatly decreased in the liver of AIDS patients.
openaire   +3 more sources

Evaluation of Candidate Anti-HIV Agents in vitro

1990
Significant progress has been made in the development of anti-HIV therapies for patients with AIDS and other HIV-related illnesses [1-4]. Because of major advances in our understanding of the HIV-1 replicative cycle and identification of potential targets for anti-retroviral therapy, many newer agents are now undergoing preclinical and clinical drug ...
openaire   +2 more sources

Discovery of novel anti-HIV agents via Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry-based approach

Expert Opinion on Drug Discovery, 2016
Ping Gao   +5 more
semanticscholar   +1 more source

Synthesis and bioevaluation of substituted chalcones, coumaranones and other flavonoids as anti-HIV agents.

Bioorganic & Medicinal Chemistry, 2016
A. Cole   +3 more
semanticscholar   +1 more source

Current Status of Anti-HIV Agents

Current Medicinal Chemistry -Anti-Infective Agents, 2005
V. Tandon, R. Chhor
openaire   +2 more sources

Home - About - Disclaimer - Privacy